TrialJournal of child and adolescent psychopharmacology2020

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.

Ann C Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.